Department of Justice Alleges Racial Bias in UCLA Medical School Admissions The Department of Justice has accused UCLA's David Geffen School of Medicine of prioritizing racial demographics over merit, sparking a legal battle over diversity and admissions laws. The United States Department of Justice, acting under the direction of the Trump administration, has launched a significant legal challenge against the David Geffen School of Medicine at UCLA. Following a detailed inquiry that spanned an entire year, federal investigators have alleged that the leadership at the medical school intentionally utilized racial demographics as a primary factor in their admissions process. According to the Department of Justice, this practice was designed to favor certain minority groups while unfairly disadvantaging highly qualified applicants who are white or of Asian descent.Harmeet K. Dhillon, an assistant attorney general, asserted that the school has allowed racial politics to overshadow the fundamental goals of merit and excellence, thereby distracting the institution from its critical mission of preparing the next generation of physicians. In response to these serious allegations, a spokesperson for UCLA has maintained that the institution is operating in full accordance with both state and federal legal frameworks.The university argues that the admissions process at the David Geffen School of Medicine is grounded in a comprehensive and rigorous review of every individual applicant. UCLA officials emphasize that their selection criteria are based on merit and that they remain committed to providing high-quality medical education to all students who meet the necessary qualifications.The university stands by its practices, suggesting that its mission to maintain a diverse and capable student body does not conflict with the legal requirements of fair admissions. A central point of contention in the Department of Justice investigation is the use of academic metrics and specialized testing. The federal report highlights discrepancies in median GPA scores, noting that for the admitted classes of 2023 and 2024, some applicant groups possessed significantly lower scores than others.Furthermore, the DOJ has taken issue with the PREview Exam, an assessment that includes open-ended questions regarding an applicant's background. The government argues that these questions are specifically designed to encourage Black and Hispanic applicants to reveal their race, allowing the school to factor racial identity into the final decision. This is viewed by the DOJ as a calculated effort to maintain racial quotas under the guise of evaluating personal experience.The legal battle also touches upon a deeper ideological divide regarding the impact of diversity on healthcare. The DOJ has explicitly rejected the theory that increasing the racial diversity of the medical workforce leads to better health outcomes for minority patients. The investigation suggests that the program director promoted this theory as a pretext to discriminate against other races.However, this contradicts various academic studies on racial concordance, which suggest that patients often experience better medical results when treated by doctors of the same race. For instance, research conducted at UCLA indicated that Hispanic Medicare patients had lower readmission rates and shorter hospital stays when they were cared for by Hispanic physicians. This investigation is part of a broader pattern of tension between the Trump administration and the University of California system.During this second term, the Department of Justice has frequently targeted UCLA, including previous probes into allegations that the university failed to address antisemitism on campus. These earlier conflicts resulted in the DOJ demanding extensive concessions to align the university with its ideological goals, accompanied by the threat of fines exceeding one billion dollars.Additionally, the administration has scrutinized the federal financial assistance provided to medical schools. While the DOJ argues that federal funding should mandate the eradication of race-based politics, the administration has simultaneously signed legislation that could limit this funding, potentially forcing students to rely on private lenders who offer fewer protections and no loan forgiveness options.Ultimately, the Department of Justice states that its primary objective is to reach an agreement with the university to ensure that all admissions practices are brought into strict legal compliance. The outcome of this dispute could have far-reaching implications for how medical schools across the country approach diversity, equity, and inclusion in their selection processes.As the legal proceedings continue, the clash between the federal government's insistence on a strict color-blind meritocracy and the university's pursuit of a representative healthcare workforce remains a pivotal point of conflict in American higher education